Who should be prioritised for COVID-19 vaccines?

doi:10.1016/S0140-6736(20)32224-8

. 2020 Nov 28;396(10264):1732-1733.

doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.

Who should be prioritised for COVID-19 vaccines?

Zaki Hassan-Smith¹, Wasim Hanif², Kamlesh Khunti³

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK. Electronic address: z.hassansmith@bham.ac.uk.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
³ Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.

PMID: 33125934
PMCID: PMC7832613
DOI: 10.1016/S0140-6736(20)32224-8

Who should be prioritised for COVID-19 vaccines?

Zaki Hassan-Smith et al. Lancet. 2020.

. 2020 Nov 28;396(10264):1732-1733.

doi: 10.1016/S0140-6736(20)32224-8. Epub 2020 Oct 27.

Authors

Zaki Hassan-Smith¹, Wasim Hanif², Kamlesh Khunti³

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK. Electronic address: z.hassansmith@bham.ac.uk.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK.
³ Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.

PMID: 33125934
PMCID: PMC7832613
DOI: 10.1016/S0140-6736(20)32224-8

No abstract available

PubMed Disclaimer

Cited by

Understanding COVID-19 Vaccine Hesitancy in Ethnic Minorities Groups in the UK.
Naqvi M, Li L, Woodrow M, Yadav P, Kostkova P. Naqvi M, et al. Front Public Health. 2022 Jul 1;10:917242. doi: 10.3389/fpubh.2022.917242. eCollection 2022. Front Public Health. 2022. PMID: 35844884 Free PMC article.
Leukopenia and leukocytosis as strong predictors of COVID-19 severity: A cross-sectional study of the hematologic abnormalities and COVID-19 severity in hospitalized patients.
Sharafi F, Jafarzadeh Esfehani R, Moodi Ghalibaf A, Jarahi L, Shamshirian A, Mozdourian M. Sharafi F, et al. Health Sci Rep. 2023 Sep 27;6(10):e1574. doi: 10.1002/hsr2.1574. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37779668 Free PMC article.
COVID-19: an outbreak in a nursing home in spring 2021.
Castaldi S, Zani S, Lai A, Zehender G, Bergna A, Boriello CR, Cereda D. Castaldi S, et al. Acta Biomed. 2021 Oct 7;92(S6):e2021445. doi: 10.23750/abm.v92iS6.12231. Acta Biomed. 2021. PMID: 34739467 Free PMC article.
Comparing COVID-19 risk factors in Brazil using machine learning: the importance of socioeconomic, demographic and structural factors.
Baqui P, Marra V, Alaa AM, Bica I, Ercole A, van der Schaar M. Baqui P, et al. Sci Rep. 2021 Aug 2;11(1):15591. doi: 10.1038/s41598-021-95004-8. Sci Rep. 2021. PMID: 34341397 Free PMC article.
Value of Immunizations during the COVID-19 Emergency.
Stefanati A, d'Anchera E, De Motoli F, Savio M, Toffoletto MV, Gabutti G. Stefanati A, et al. Int J Environ Res Public Health. 2021 Jan 18;18(2):778. doi: 10.3390/ijerph18020778. Int J Environ Res Public Health. 2021. PMID: 33477591 Free PMC article. Review.

See all "Cited by" articles

References

1. Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...
1. Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed
1. Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19
1. Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed
1. Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...

[2] Department of Health and Social Care Joint Committee on Vaccination and Immunisation: interim advice on priority groups for COVID-19 vaccination. Sept 25, 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavir...

[3] Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed

[4] Barron E, Bakhai C, Kar P. Type 1 and type 2 diabetes and COVID-19 related mortality in England: a whole population study. Lancet Diabetes Endocrinol. 2020;8:813–822. - PMC - PubMed

[5] Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19

[6] Khunti K, Routen A, Patel K. COVID-19 in Black, Asian and Minority Ethnic populations: an evidence review and recommendations from the South Asian Health Foundation. June 16, 2020. https://www.sahf.org.uk/covid19

[7] Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed

[8] Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458–2459. - PubMed

[9] Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

[10] Hippisley-Cox J, Clift AK, Coupland CAC. Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population. medRxiv. 2020 doi: 10.1101/2020.06.28.20141986. published online June 29. (preprint) - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Who should be prioritised for COVID-19 vaccines?

Affiliations

Who should be prioritised for COVID-19 vaccines?

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical